3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design-Reference-Cited by-同舟云学术

3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design

Published:2009-03-28 Issue:1 Volume:14 Page:27-38
ISSN:1381-1991
Container-title:Molecular Diversity
language:en
Short-container-title:Mol Divers

Author:

Nandi Sisir,Bagchi Manish C.

Publisher

Springer Science and Business Media LLC

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Drug Discovery,Molecular Biology,General Medicine,Information Systems,Catalysis

Link

http://link.springer.com/content/pdf/10.1007/s11030-009-9137-9.pdf

Reference27 articles.

1. Herbst RS, Fukuoka M, Baselga J (2004) Gefitinib-a novel targeted approach to treating cancer. Nat Rev Cancer 4: 956–965. doi: 10.1038/nrc1506

2. Ballard P, Bradbury RH, Hennequin LFA, Hickinson DM, Johnson PD, Kettle JG, Klinowska T, Morgentin R, Ogilvie DJ, Olivier A (2005) 5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorg Med Chem Lett 15: 4226–4229. doi: 10.1016/j.bmcl.2005.06.068

3. Rewcastle GW, Denny WA, Bridges AJ, Zhou H, Cody DR, McMichael A, Fry DW (1995) Tyrosine kinase inhibitors. 5. Synthesis and structure–activity relationships for 4-[(phenylmethyl) amino]- and 4-(phenylamino)quinazolines as potent adeonosine-5^ʹ-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor. J Med Chem 38: 3482–3487. doi: 10.1021/jm00018a008

4. Gibson KH, Grundy W, Godfrey AA, Woodburn JR, Ashton SE, Curry BJ, Scarlett L, Barker AJ, Brown DS (1997) Epidermal growth factor receptor tyrosine kinase: structure–activity relationships and antitumour activity of novel quinazolines. Bioorg Med Chem Lett 7: 2723–2728. doi: 10.1016/S0960-894X(97)10059-2

5. Hennequin LFA, Ballard P, Boyle FT, Delouvrie B, Ellston RPA, Halsall CT, Harris CS, Hudson K, Kendrew J, Pease JE, Ross HS, Smith P, Vincent JL (2006) Novel 4-anilinoquinazolines with C-6 carbon-linked side chains: synthesis and structure–activity relationship of a series of potent, orally active, EGF receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett 16: 2672–2676. doi: 10.1016/j.bmcl.2006.02.025

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel PLGA-encapsulated-nanopiperine promotes synergistic interaction of p53/PARP-1/Hsp90 axis to combat ALX-induced-hyperglycemia;Scientific Reports;2024-04-25

2. Discovery of potential epidermal growth factor receptor inhibitors from black pepper for the treatment of lung cancer: an in-silico approach;In Silico Pharmacology;2024-04-08

3. Exploring a new phyto-derived nanoparticle for targeting bacterial protein EF-Tu: an integrated approach to develop antimicrobial drug;Smart Science;2024-04-02

4. Enhanced Drug Carriage Efficiency of Curcumin-Loaded PLGA Nanoparticles in Combating Diabetic Nephropathy via Mitigation of Renal Apoptosis;Journal of Pharmacopuncture;2024-03-31

5. Phytochemicals for Cancer Treatment: An Update on Plant-Derived Anti-Cancer Compounds and their Mechanisms of Action;Current Topics in Medicinal Chemistry;2024-03-27